CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Gruppo Italiano Studio Linfomi

Gruppo Italiano Studio Linfomi

Academic/Hospital

Also known as: Fondazione Italiana Linfomi - ETS | Gruppo Italiano Studi Linfomi

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 1, 2026

Timeline

1980s

Jan 1, 1988
Gruppo Italiano Studio Linfomi— Founded

Drugs by trial phase (31 distinct, 15 trials)

Phase 3 (15 own, 0 via acquisition)

Phase 2 (16 own, 0 via acquisition)

Indications

Studied for

Recent trials (18)

NCT07207785Lead sponsorPhase 2Feb 1, 2026
NCT06492837Lead sponsorPhase 2Sep 15, 2024
NCT05966233Lead sponsorPhase 2Jan 31, 2024
NCT05977673Lead sponsorPhase 2Dec 31, 2023
NCT05300282Lead sponsorPhase 1/Phase 2Dec 31, 2022
NCT01274403Lead sponsorPhase 2Dec 28, 2010
NCT01686386Lead sponsorPhase 1/Phase 2Feb 1, 2010
NCT01830478Lead sponsorPhase 2Apr 1, 2009
NCT01830478Overall official - principal investigatorPhase 2Apr 1, 2009
NCT01830465Overall official - principal investigatorPhase 2Aug 1, 2006
NCT01830465Lead sponsorPhase 2Aug 1, 2006
NCT01018758Lead sponsorPhase 2Jul 1, 2006
NCT01018758Overall official - principal investigatorPhase 2Jul 1, 2006
NCT00016887CollaboratorPhase 3Dec 1, 2000
NCT00866203Lead sponsorPhase 3Oct 1, 2000

Details

Founded: Modena, IT Jan 1, 1988
Last known activity: Feb 1, 2026